Search results
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 2 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 3 days agoThe U.S. Department of Health and Human Services (HHS) said on Thursday it will provide up to $500...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 3 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 4 days agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
WHO confirms rare human case of bird flu infection in India
The Independent via Yahoo News· 4 days ago“Conjunctivitis...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 2 days agoCyanVac and its affiliate Blue Lake Biotechnology are developing the single-dose, intranasal vaccine...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 1 day agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 1 day agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...
FDA expands RSV vaccine use to adults aged 50 to 59
Center for Infectious Disease Research and Policy· 6 days agoGSK said recent studies have shown RSV causes approximately 42,000 annual hospitalizations in adults aged 50 to 59.
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 6 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...